Interferon-lambda and therapy for chronic hepatitis C virus infection
about
Immunity to Pathogens Taught by Specialized Human Dendritic Cell SubsetsInterferon-λ: Immune Functions at Barrier Surfaces and BeyondSTAT proteins - key regulators of anti-viral responses, inflammation, and tumorigenesis in the liverThe Concise Guide to PHARMACOLOGY 2013/14: catalytic receptors.Endogenous intrahepatic IFNs and association with IFN-free HCV treatment outcome.Interferons: Success in anti-viral immunotherapy.Type III interferons, IL-28 and IL-29, are increased in chronic HCV infection and induce myeloid dendritic cell-mediated FoxP3+ regulatory T cellsIFN-λ Inhibits MiR-122 Transcription through a Stat3-HNF4α Inflammatory Feedback Loop in an IFN-α Resistant HCV Cell Culture System.The role of macrophage IL-10/innate IFN interplay during virus-induced asthma.Long-term antiviral efficacy of entecavir and liver histology improvement in Chinese patients with hepatitis B virus-related cirrhosis.Cytokines and HCV-related disorders.The impact of interferon lambda 3 gene polymorphism on natural course and treatment of hepatitis CEffect of different interferonα2 preparations on IP10 and ET-1 release from human lung cells.Interferon-lambda (IFN-λ) induces signal transduction and gene expression in human hepatocytes, but not in lymphocytes or monocytes.Pharmacokinetic studies of the recombinant chicken interferon-α in broiler chickens.Glucocorticosteroids enhance replication of respiratory viruses: effect of adjuvant interferon.IL28B polymorphisms as a pretreatment predictor of response to HCV treatment.Cytokines and HCV-related autoimmune disorders.Peginterferon Lambda-1a, a New Therapeutic for Hepatitis C Infection, from Bench to Clinic.Generation and characterization of interferon-lambda 1-resistant H1N1 influenza A viruses.Cellular Mechanism for Impaired Hepatitis C Virus Clearance by Interferon Associated with IFNL3 Gene Polymorphisms Relates to Intrahepatic Interferon-λ Expression.Development of tropical spastic paraparesis in human T-lymphotropic virus type 1 carriers is influenced by interleukin 28B gene polymorphisms.High-throughput quantitative real-time RT-PCR assay for determining expression profiles of types I and III interferon subtypes.Induction and Antagonism of Antiviral Responses in Respiratory Syncytial Virus-Infected Pediatric Airway Epithelium.IL-26 is overexpressed in chronically HCV-infected patients and enhances TRAIL-mediated cytotoxicity and interferon production by human NK cells.Pegylated interferons Lambda-1a and alfa-2a display different gene induction and cytokine and chemokine release profiles in whole blood, human hepatocytes and peripheral blood mononuclear cells.Genetic variation in interleukin 28B and correlation with chronic hepatitis B virus infection in Saudi Arabian patients.
P2860
Q26777195-684E4DEB-CE02-4E50-BFB0-70375F60DD5DQ26801049-3A8D07BF-14A2-466B-AB51-CB494571EC3EQ27000742-33E06EBA-A7CB-4D8F-95BA-0ED677DF9C18Q30486741-04A1CF3F-C26C-4984-AB7D-DEB55E116173Q33944295-DF363BE3-4D11-4874-8F93-342A09E4056BQ34276038-611BCF87-8E4B-404C-977D-7904EFB39CB7Q34446790-70DCC32D-0E5E-4399-831B-BBE18570B8FFQ34504772-2B5C3DA0-FCE0-40CD-93DF-2BD0FCD8567EQ35046046-E949C424-BE23-4613-885D-B15645E0503BQ35819595-27145D72-3462-4896-BC80-56D4879AAF7DQ35960209-0824F16F-2C87-4E12-A515-89081885EEB1Q36208380-F9743A9C-4E6A-4417-A606-A5EAD4F4E0C1Q36303468-A9C94F13-0168-4B6E-8FF8-97721E07F527Q36628598-996FBAC8-8FD2-4502-9DB9-E870ECB43277Q37667570-BE591076-15FA-4968-8901-C882D2B1C448Q37741110-059B9A7C-4C74-446F-9E0E-1A388B483FACQ38053543-D4A5B4F0-7D7B-493B-B7CB-381AEEF19E8AQ38266253-38CAEE3E-8EF7-4750-BEBD-51AB858B267DQ38584280-25D1B83B-AE06-4D7A-9DB1-D6B4944169ACQ38696286-FF7FC4A4-D899-4897-BFC1-4125EFA05EBFQ38792478-4BD007C7-D7D9-4105-886C-6C6B0343A413Q39533372-B4CD7267-ACE1-4ABB-ACE2-247D147E1723Q39743537-3E8ED065-9552-4666-A37B-CEB293E49D24Q40480803-34E19F5B-4544-4738-8F92-AAC9206A095CQ41756934-B3D70418-E4D8-4E00-A823-6F2658B44D5EQ42218832-BF488EA4-AD7D-4A45-A3F8-9DA104DC0A55Q42263068-F44A5EDB-3B39-44A1-A0E1-4EA96155FA86
P2860
Interferon-lambda and therapy for chronic hepatitis C virus infection
description
2011 nî lūn-bûn
@nan
2011 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Interferon-lambda and therapy for chronic hepatitis C virus infection
@ast
Interferon-lambda and therapy for chronic hepatitis C virus infection
@en
type
label
Interferon-lambda and therapy for chronic hepatitis C virus infection
@ast
Interferon-lambda and therapy for chronic hepatitis C virus infection
@en
prefLabel
Interferon-lambda and therapy for chronic hepatitis C virus infection
@ast
Interferon-lambda and therapy for chronic hepatitis C virus infection
@en
P2860
P356
P1433
P1476
Interferon-lambda and therapy for chronic hepatitis C virus infection
@en
P2093
Harold Dickensheets
Thomas R O'Brien
P2860
P304
P356
10.1016/J.IT.2011.07.002
P577
2011-08-05T00:00:00Z